Many gay and bisexual men uninformed about anti-HIV drug

accreditation
PrEP – iStock
PrEP – iStock

Many gay and bisexual men don't know about a drug therapy that can protect them from HIV, a new study suggests.

Lack of discussion

A once-a-day pill known as PrEP – short for pre-exposure prophylaxis medication – has been found to reduce HIV infection by 92 percent in people at high risk for the Aids-causing virus, including men who have unprotected gay sex, the researchers said.

The researchers studied 2014 data from 401 HIV-negative gay and bisexual men in Baltimore. Only 42 percent knew about PrEP. Those who had been tested for HIV in the previous year were more likely to be aware of it.

But having recently seen a doctor or getting tested for another sexually transmitted disease did not increase the likelihood that gay or bisexual men knew about the preventive drug, the researchers from the Johns Hopkins Bloomberg School of Public Health found.

Read: Lesbian, gay and bi adults

The findings suggest many health care providers don't discuss PrEP with gay and bisexual men and other high-risk patients, even though the US Centres for Disease Control and Prevention recommends the therapy for them.

"Doctors have limited time with their patients, but with gay and bisexual male patients, physicians definitely need to make it a point to discuss HIV risks and whether PrEP is a good option," said study leader Julia Raifman. She is a postdoctoral fellow in the department of epidemiology.

A 'game-changer'

"Health care providers may be unfamiliar with PrEP or may be uncomfortable broaching sexual health topics with their patients. Whatever the reason, we need to find a way to get PrEP to the people who can most benefit," Raifman said in a Hopkins news release.

"PrEP could be a game-changer for HIV in the United States, where there are more than 44,000 new cases of HIV every year – but only if people know about it," she said.

Read: Gay men face healthcare obstacles in Africa

In 2011, the rate of HIV infection among gay and bisexual men in the United States was 18 percent.

Since the US Food and Drug Administration approved PrEP in 2012, only 5 percent of high-risk people have taken it for HIV prevention, according to the researchers.

The study findings were published online recently in the American Journal of Preventive Medicine.

Read more:

Few US doctors knowledgeable about LGBT health

The horror of 'corrective' rape

The verdict is in: homosexuality is not a choice

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Voting Booth
Eskom has considered continuous load shedding at Stage 2, instead of introducing it when the power system faces a crunch. What are your thoughts?
Please select an option Oops! Something went wrong, please try again later.
Results
I'm all for it - we're going to have power cuts regardless, so we might as well have some stability to better plan our lives
45% - 4107 votes
No thanks! I prefer having periods of no load shedding and we cannot normalise this crisis
55% - 4970 votes
Vote
Rand - Dollar
17.93
-1.8%
Rand - Pound
19.45
+0.1%
Rand - Euro
17.37
+0.2%
Rand - Aus dollar
11.70
+0.2%
Rand - Yen
0.13
+0.2%
Gold
1,643.66
0.0%
Silver
18.87
0.0%
Palladium
2,073.00
0.0%
Platinum
858.50
0.0%
Brent Crude
86.15
-5.0%
Top 40
57,110
-3.1%
All Share
63,417
-2.9%
Resource 10
56,319
-7.5%
Industrial 25
78,436
-1.2%
Financial 15
14,142
-1.6%
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE